The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 25375908 |
9 |
Targeting aldose reductase for the treatment of diabetes complications and inflammatory diseases: new insights and future directions. |
Universit£ |
| 22104435 |
54 |
Design, synthesis, and biological evaluation of novel (1-thioxo-1,2,3,4-tetrahydro-ß-carbolin-9-yl)acetic acids as selective inhibitors for AKR1B1. |
University of Toyama |
| 20936791 |
32 |
A diverse series of substituted benzenesulfonamides as aldose reductase inhibitors with antioxidant activity: design, synthesis, and in vitro activity. |
Aristotle University of Thessaloniki |
| 20304656 |
31 |
Chromene-3-carboxamide derivatives discovered from virtual screening as potent inhibitors of the tumour maker, AKR1B10. |
Gifu Pharmaceutical University |
| 16107153 |
10 |
Structure of aldehyde reductase holoenzyme in complex with the potent aldose reductase inhibitor fidarestat: implications for inhibitor binding and selectivity. |
Monash University (Parkville Campus) |
| 10882376 |
7 |
A potent aldose reductase inhibitor, (2S,4S)-6-fluoro-2', 5'-dioxospiro[chroman-4,4'-imidazolidine]-2-carboxamide (Fidarestat): its absolute configuration and interactions with the aldose reductase by X-ray crystallography. |
Rational Drug Design Laboratories |
| 28976752 |
51 |
Synthesis of Potent and Selective Inhibitors of Aldo-Keto Reductase 1B10 and Their Efficacy against Proliferation, Metastasis, and Cisplatin Resistance of Lung Cancer Cells. |
Gifu Pharmaceutical University |
Search and Browse
